Your browser doesn't support javascript.
loading
Secular trends in opioid prescribing in the USA.
Pezalla, Edmund J; Rosen, David; Erensen, Jennifer G; Haddox, J David; Mayne, Tracy J.
Afiliación
  • Pezalla EJ; Bioconsult, LLC, Wethersfield.
  • Rosen D; Purdue Pharma L.P., Stamford, CT.
  • Erensen JG; Purdue Pharma L.P., Stamford, CT.
  • Haddox JD; Purdue Pharma L.P., Stamford, CT; Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA.
  • Mayne TJ; Purdue Pharma L.P., Stamford, CT.
J Pain Res ; 10: 383-387, 2017.
Article en En | MEDLINE | ID: mdl-28243142
Opioid abuse and misuse in the USA is a public health crisis. The use of prescription opioid analgesics increased substantially from 2002 through 2010, then plateaued and began to decrease in 2011. This study examined prescriptions of branded and generic immediate- and extended-release opioid analgesics from 1992 to 2016. This was juxtaposed against state and federal policies designed to decrease overutilization and abuse, as well as the launch of new opioid products, including opioids with abuse-deterrent properties (OADPs). The data indicate that these health policies, including the utilization and reimbursement of OADPs, have coincided with decreased opioid utilization. The hypothesis that OADPs will paradoxically increase opioid prescribing is not supported.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pain Res Año: 2017 Tipo del documento: Article Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pain Res Año: 2017 Tipo del documento: Article Pais de publicación: Nueva Zelanda